technologymarketplacecurrent R&Dservicesnewsemail

Home

company info

about us

management
and board of
directors


scientific
advisory
board

 

video

View our
Small Particle
Crystalization Proces:


 

CritiTech, Inc. conducts research and development into the production and application of fine-particle compounds. The company has expanded its operations to include applications in fine particle API production, coatings, and internal product development.

Recent News & Press Releases

September 2008 :: Nanotax Collaboration Article

July 31, 2008 :: Phase 1 Trial for Nanotax has begun at
                                   the Kansas University Medical Center


news archive

contact info

CritiTech, Inc.
1321 Wakarusa Dr.
Suite 2102
Lawrence Kansas
66049
USA


ph: 785.841.7120
fax: 785.841.7268


info@crititech.com

downloads

nanotax product
profile (.doc)


production of
fine particles
with ultrasonic
energy (PDF)


nanotax ovarian
cancer mouse
model (PDF)


upcoming and
recent events


 

 

home | technology | marketplace | current R&D | services | email us
about us | management & board of directors | scientific advisory board | news

© 2007 CritiTech, Inc. : All Rights Reserved